-
-
-
-
-
-
-
Omeros (OMER) Narsoplimab Pivotal Trial Data Shared in Oral Presentation at EHA
-
-
-
-
-
-
-
Omeros (OMER) Announces BLA for Narsoplimab in HSCT-TMA Accepted for Priority Review by U.S. FDA
-
-
-
-
12,348 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All